Proposal ties financial incentives to development of drugs for neglected diseases.
نویسنده
چکیده
منابع مشابه
Expert Delphi survey on research and development into drugs for neglected diseases
BACKGROUND Tropical infectious diseases are called neglected, because they are, inter alia, characterized by an R&D deficit. A similar deficit exists for rare (orphan) diseases which neither promise a sufficient return on R&D investment. To encourage the development of treatments for rare diseases, orphan drug acts were created which contain financial and non-financial incentives for the pharma...
متن کاملBuilding local research and development capacity for the prevention and cure of neglected diseases: the case of India.
This paper examines the proposal to build research and development (R&D) capabilities for dealing with neglected infectious and tropical diseases in countries where they are endemic, as a potentially cost- and time-effective way to fill the gap between the supply of and need for new medicines. With reference to the situation in India, we consider the competencies and incentives needed by compan...
متن کاملThe roles of patents and research and development incentives in biopharmaceutical innovation.
Patents and other forms of intellectual property protection play essential roles in encouraging innovation in biopharmaceuticals. As part of the "21st Century Cures" initiative, Congress is reviewing the policy mechanisms designed to accelerate the discovery, development, and delivery of new treatments. Debate continues about how best to balance patent and intellectual property incentives to en...
متن کاملTake the Money and Run: The Challenges of Designing and Evaluating Financial Incentives in Healthcare; Comment on “Paying for Performance in Healthcare Organisations”
Many countries are turning their attention to the use of explicit financial incentives to drive desired improvements in healthcare performance. However, we have only a weak evidence-base to inform policy in this area. The research challenge is to generate robust evidence on what financial incentives work, under what circumstances, for whom and with what intended and unintended consequences.
متن کاملPotential interactions of the Orphan Drug Act and pharmacogenomics: a flood of orphan drugs and abuses?
To overcome the unattractiveness of small markets, the United States govemment provides financial aid and incentives for drug manufacturers to create cures for rare diseases under the Orphan Drug Act ("the Act").' Recent research integrating genetic information and pharmacology holds promise for creating more effective drugs targeted at smaller populations than ever before. In the near future, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
دوره 63 8 شماره
صفحات -
تاریخ انتشار 2006